CN114533852A — 一种复方阿莫西林硫酸黏菌素混悬注射液及其制备方法
Assigned to Sichuan Hengtong Animal Protection Biotechnology Co ltd · Expires 2022-05-27 · 4y expired
What this patent protects
本发明公开了一种复方阿莫西林硫酸黏菌素混悬注射液,包括以下按重量份数配比的原料:阿莫西林原料药9份‑11份,硫酸黏菌素原料药1份‑2份,助悬剂2份‑5份,抗氧剂0.5份‑1份,分散剂2份‑5份,分散媒介79份‑95份。本发明还公开了一种复方阿莫西林硫酸黏菌素混悬注射液的制备方法。本发明制备得到的复方阿莫西林硫酸黏菌素混悬注射液通过特定助悬剂和分散剂的协同增效作用,提升药物溶出度,同时改变阿莫西林硫酸黏菌素混悬注射液易沉降、板结的问题,提高药物稳定性。
USPTO Abstract
本发明公开了一种复方阿莫西林硫酸黏菌素混悬注射液,包括以下按重量份数配比的原料:阿莫西林原料药9份‑11份,硫酸黏菌素原料药1份‑2份,助悬剂2份‑5份,抗氧剂0.5份‑1份,分散剂2份‑5份,分散媒介79份‑95份。本发明还公开了一种复方阿莫西林硫酸黏菌素混悬注射液的制备方法。本发明制备得到的复方阿莫西林硫酸黏菌素混悬注射液通过特定助悬剂和分散剂的协同增效作用,提升药物溶出度,同时改变阿莫西林硫酸黏菌素混悬注射液易沉降、板结的问题,提高药物稳定性。
Drugs covered by this patent
- Prograf (TACROLIMUS) · Astellas Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.